[Form 4] CARDINAL HEALTH INC Insider Trading Activity

Rhea-AI Filing Summary

Cardinal Health Chief Information Officer Michelle D. Greene reported two open-market sales of Cardinal Health common shares. On February 27, 2026, she sold 100 shares at $228.55 and 2,646 shares at $228.47, for a total of 2,746 shares sold. After these transactions, she directly owned 12,230 common shares of Cardinal Health.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Greene Michelle D.

(Last) (First) (Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN OH 43017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	02/27/2026		S		100	D	$228.55	14,876	D
Common Shares	02/27/2026		S		2,646	D	$228.47	12,230	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Laura C. Dhaliwal, Attorney-in-fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Cardinal Health (CAH) executive Michelle D. Greene report in this Form 4?

Cardinal Health Chief Information Officer Michelle D. Greene reported selling 2,746 common shares in open-market transactions. These trades were executed on February 27, 2026, and were reported as direct ownership transactions in Cardinal Health stock.

How many Cardinal Health (CAH) shares did Michelle D. Greene sell and at what prices?

Michelle D. Greene sold a total of 2,746 Cardinal Health common shares. She sold 100 shares at $228.55 per share and 2,646 shares at $228.47 per share, all as open-market sales on February 27, 2026.

What type of transactions were reported by Cardinal Health (CAH) executive Michelle D. Greene?

The filing shows two non-derivative, open-market sales of Cardinal Health common shares coded as “S.” Both transactions involved direct ownership and are described as sales in the open market or private transactions under SEC reporting rules.

How many Cardinal Health (CAH) shares does Michelle D. Greene own after these sales?

Following the reported transactions, Michelle D. Greene directly owns 12,230 Cardinal Health common shares. This post-transaction holding reflects her remaining direct equity position after selling a combined 2,746 shares on February 27, 2026.

Does this Cardinal Health (CAH) Form 4 show net buying or selling by Michelle D. Greene?

The Form 4 shows net selling activity by Michelle D. Greene. She executed two open-market sales totaling 2,746 shares, with no reported share purchases or grants, resulting in a net-sell direction for this reporting period.

What is Michelle D. Greene’s role at Cardinal Health (CAH) mentioned in this Form 4?

Michelle D. Greene is identified as the Chief Information Officer of Cardinal Health. Her officer status is disclosed in the filing, and the reported stock transactions relate to her position as a Section 16 reporting officer of the company.